Table of Contents

2019-2024 Global Humira Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Humira Consumption 2014-2024
  • 2.1.2 Humira Consumption CAGR by Region
• 2.2 Humira Segment by Type
  • 2.2.1 Humira Syringe
  • 2.2.2 Humira Pen
• 2.3 Humira Consumption by Type
  • 2.3.1 Global Humira Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Humira Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Humira Sale Price by Type (2014-2019)
• 2.4 Humira Segment by Application
  • 2.4.1 Ankylosing Spondylitis
  • 2.4.2 Rheumatoid Arthritis
  • 2.4.3 Crohn’s Disease
  • 2.4.4 Other
• 2.5 Humira Consumption by Application
  • 2.5.1 Global Humira Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Humira Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Humira Sale Price by Application (2014-2019)

3 Global Humira by Players

• 3.1 Global Humira Sales Market Share by Players
  • 3.1.1 Global Humira Sales by Players (2017-2019)
  • 3.1.2 Global Humira Sales Market Share by Players (2017-2019)
• 3.2 Global Humira Revenue Market Share by Players
  • 3.2.1 Global Humira Revenue by Players (2017-2019)
  • 3.2.2 Global Humira Revenue Market Share by Players (2017-2019)
• 3.3 Global Humira Sale Price by Players
• 3.4 Global Humira Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Humira Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Humira Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Humira by Regions

• 4.1 Humira by Regions
  • 4.1.1 Global Humira Consumption by Regions
  • 4.1.2 Global Humira Value by Regions
• 4.2 Americas Humira Consumption Growth
• 4.3 APAC Humira Consumption Growth
• 4.4 Europe Humira Consumption Growth
• 4.5 Middle East & Africa Humira Consumption Growth

5 Americas

• 5.1 Americas Humira Consumption by Countries
  • 5.1.1 Americas Humira Consumption by Countries (2014-2019)
  • 5.1.2 Americas Humira Value by Countries (2014-2019)
• 5.2 Americas Humira Consumption by Type
• 5.3 Americas Humira Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Humira Consumption by Countries
  • 6.1.1 APAC Humira Consumption by Countries (2014-2019)
  • 6.1.2 APAC Humira Value by Countries (2014-2019)
• 6.2 APAC Humira Consumption by Type
• 6.3 APAC Humira Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Humira by Countries
  • 7.1.1 Europe Humira Consumption by Countries (2014-2019)
  • 7.1.2 Europe Humira Value by Countries (2014-2019)
• 7.2 Europe Humira Consumption by Type
• 7.3 Europe Humira Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Humira by Countries
  • 8.1.1 Middle East & Africa Humira Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Humira Value by Countries (2014-2019)
• 8.2 Middle East & Africa Humira Consumption by Type
• 8.3 Middle East & Africa Humira Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Humira Distributors
• 10.3 Humira Customer

11 Global Humira Market Forecast

• 11.1 Global Humira Consumption Forecast (2019-2024)
• 11.2 Global Humira Forecast by Regions
  • 11.2.1 Global Humira Forecast by Regions (2019-2024)
  • 11.2.2 Global Humira Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Humira Forecast by Type
• 11.8 Global Humira Forecast by Application

12 Key Players Analysis

• 12.1 AbbVie
  • 12.1.1 Company Details
  • 12.1.2 Humira Product Offered
  • 12.1.3 AbbVie Humira Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 AbbVie News
• 12.2 Eisai
  • 12.2.1 Company Details
  • 12.2.2 Humira Product Offered
  • 12.2.3 Eisai Humira Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Eisai News
• 12.3 Cadila Healthcare
  • 12.3.1 Company Details
  • 12.3.2 Humira Product Offered
  • 12.3.3 Cadila Healthcare Humira Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Cadila Healthcare News
• 12.4 Torrent Pharmaceuticals
  • 12.4.1 Company Details
  • 12.4.2 Humira Product Offered
  • 12.4.3 Torrent Pharmaceuticals Humira Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Torrent Pharmaceuticals News
• 12.5 Amgen
  • 12.5.1 Company Details
  • 12.5.2 Humira Product Offered
  • 12.5.3 Amgen Humira Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Amgen News
• 12.6 Boehringer Ingelheim
  • 12.6.1 Company Details
  • 12.6.2 Humira Product Offered
  • 12.6.3 Boehringer Ingelheim Humira Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Boehringer Ingelheim News

...

13 Research Findings and Conclusion

Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion in 2017 is about 43%, and the proportion is in decreasing trend from 2013 to 2017.
USA is the largest market, with a sales market share nearly 65% in 2017. Following USA, Europe is the second largest market with the sales market share of 30%.

According to this study, over the next five years the Humira market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Humira business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Humira market by product type, application, key manufacturers and key regions and countries.

This study considers the Humira value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Humira Syringe
Humira Pen
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AbbVie
Eisai
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Humira consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Humira market by identifying its various subsegments.
Focuses on the key global Humira manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Humira with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Humira submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.